This trial is active, not recruiting.

Conditions endotoxemia, sepsis
Treatment e. coli endotoxin
Sponsor Herlev Hospital
Start date March 2004
End date January 2005
Trial identifier NCT00197899, KA 04015


The purpuse of this study is to examine the acute phase respons when different doses of E. Coli Endotoxin is injected in healty volunters.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model crossover assignment
Masking double-blind
Primary purpose diagnostic

Eligibility Criteria

Male participants from 18 years up to 40 years old.

Inclusion Criteria: Healty volunteers - Exclusion Criteria: Infection 14 days prior to the trial Regular medication Present and /or former heart disease -

Additional Information

Principal investigator Dorthe H Olsen, MD
Trial information was received from ClinicalTrials.gov and was last updated in December 2005.
Information provided to ClinicalTrials.gov by Herlev Hospital.